{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:42:25Z","timestamp":1775151745825,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["R01 AI049153"],"award-info":[{"award-number":["R01 AI049153"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.vaccine.2009.10.051","type":"journal-article","created":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T08:28:20Z","timestamp":1256891300000},"page":"299-308","source":"Crossref","is-referenced-by-count":28,"title":["Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIVmac251 challenge"],"prefix":"10.1016","volume":"28","author":[{"given":"Elizabeth J.","family":"Faul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pyone P.","family":"Aye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy B.","family":"Papaneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bapi","family":"Pahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"McGettigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith","family":"Schiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna","family":"Chervoneva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew A.","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias J.","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"August (4)","key":"10.1016\/j.vaccine.2009.10.051_bib1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1086\/505979","article-title":"HIV vaccines: new frontiers in vaccine development","volume":"43","author":"Duerr","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"November (9653)","key":"10.1016\/j.vaccine.2009.10.051_bib2","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"issue":"November (9653)","key":"10.1016\/j.vaccine.2009.10.051_bib3","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"McElrath","year":"2008","journal-title":"Lancet"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.10.051_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ni1296","article-title":"HIV vaccine design: insights from live attenuated SIV vaccines","volume":"7","author":"Koff","year":"2006","journal-title":"Nat Immunol"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2009.10.051_bib5","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1086\/512243","article-title":"Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease","volume":"195","author":"McKenna","year":"2007","journal-title":"J Infect Dis"},{"issue":"May (Pt 5)","key":"10.1016\/j.vaccine.2009.10.051_bib6","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1099\/vir.0.80844-0","article-title":"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies","volume":"86","author":"Faber","year":"2005","journal-title":"J Gen Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.10.051_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.77.1.237-244.2003","article-title":"Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic","volume":"77","author":"McGettigan","year":"2003","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.10.051_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/viro.2001.1212","article-title":"Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines","volume":"292","author":"Siler","year":"2002","journal-title":"Virology"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.10.051_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.tibtech.2007.05.004","article-title":"HIV\/AIDS: in search of an animal model","volume":"25","author":"Ambrose","year":"2007","journal-title":"Trends Biotechnol"},{"issue":"June (4959)","key":"10.1016\/j.vaccine.2009.10.051_bib10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.2160735","article-title":"Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus","volume":"248","author":"Kestler","year":"1990","journal-title":"Science"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.10.051_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1399-0039.1997.tb02927.x","article-title":"A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing","volume":"50","author":"Knapp","year":"1997","journal-title":"Tissue Antigens"},{"issue":"August (12)","key":"10.1016\/j.vaccine.2009.10.051_bib12","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/01.aids.0000131393.76221.cc","article-title":"Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect","volume":"18","author":"Smith","year":"2004","journal-title":"AIDS"},{"issue":"December (23)","key":"10.1016\/j.vaccine.2009.10.051_bib13","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1128\/JVI.74.23.11001-11007.2000","article-title":"Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection","volume":"74","author":"Veazey","year":"2000","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.10.051_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/JVI.74.1.57-64.2000","article-title":"Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo","volume":"74","author":"Veazey","year":"2000","journal-title":"J Virol"},{"issue":"November (1\u20132)","key":"10.1016\/j.vaccine.2009.10.051_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jim.2003.08.003","article-title":"Detection of antigen-specific T cell interferon gamma expression by ELISPOT and cytokine flow cytometry assays in rhesus macaques","volume":"282","author":"Pahar","year":"2003","journal-title":"J Immunol Methods"},{"issue":"June (1)","key":"10.1016\/j.vaccine.2009.10.051_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virol.2007.01.010","article-title":"Virus-specific T cell responses in macaques acutely infected with SHIV(sf162p3)","volume":"363","author":"Pahar","year":"2007","journal-title":"Virology"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2009.10.051_bib17","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20031266","article-title":"Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection","volume":"198","author":"Veazey","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.10.051_bib18","series-title":"Current protocols in immunology","article-title":"Evaluating neutralizing antibodies against HIV, SIV and SHIV in luciferase reporter gene assays","author":"Montefiori","year":"2004"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2009.10.051_bib19","doi-asserted-by":"crossref","first-page":"17291","DOI":"10.1074\/jbc.M108232200","article-title":"Association of chemokine-mediated block to HIV entry with coreceptor internalization","volume":"277","author":"Brandt","year":"2002","journal-title":"J Biol Chem"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2009.10.051_bib20","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"Li","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.10.051_bib21","series-title":"Linear and nonlinear models for the analysis of repeated measurements","author":"Vonesh","year":"1997"},{"key":"10.1016\/j.vaccine.2009.10.051_bib22","series-title":"Linear mixed models for longitudinal data","author":"Verbeke","year":"2000"},{"key":"10.1016\/j.vaccine.2009.10.051_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/biomet\/75.2.383","article-title":"A comparison of two modified Bonferroni procedures","volume":"75","author":"Hommel","year":"1988","journal-title":"Biometrika"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2009.10.051_bib24","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1128\/JVI.00292-08","article-title":"Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive Simian immunodeficiency virus-infected rhesus macaques","volume":"82","author":"Maness","year":"2008","journal-title":"J Virol"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2009.10.051_bib25","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1128\/JVI.80.10.5074-5077.2006","article-title":"The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication","volume":"80","author":"Yant","year":"2006","journal-title":"J Virol"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2009.10.051_bib26","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1073\/pnas.87.16.6058","article-title":"Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals","volume":"87","author":"Schnittman","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2009.10.051_bib27","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.4049\/jimmunol.174.12.8191","article-title":"Correlates of delayed disease progression in HIV-1-infected Kenyan children","volume":"174","author":"Chakraborty","year":"2005","journal-title":"J Immunol"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2009.10.051_bib28","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.10.051_bib29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"issue":"August (5431)","key":"10.1016\/j.vaccine.2009.10.051_bib30","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.285.5431.1261","article-title":"Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus","volume":"285","author":"Stahl-Hennig","year":"1999","journal-title":"Science"},{"issue":"April (5362)","key":"10.1016\/j.vaccine.2009.10.051_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1126\/science.280.5362.427","article-title":"Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection","volume":"280","author":"Veazey","year":"1998","journal-title":"Science"},{"issue":"November (21)","key":"10.1016\/j.vaccine.2009.10.051_bib32","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1128\/JVI.01129-08","article-title":"Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge","volume":"82","author":"Demberg","year":"2008","journal-title":"J Virol"},{"issue":"June (5577)","key":"10.1016\/j.vaccine.2009.10.051_bib33","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.1070441","article-title":"Diversity considerations in HIV-1 vaccine selection","volume":"296","author":"Gaschen","year":"2002","journal-title":"Science"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.10.051_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/72318","article-title":"Protection of macaques against vaginal transmission of a pathogenic HIV-1\/SIV chimeric virus by passive infusion of neutralizing antibodies","volume":"6","author":"Mascola","year":"2000","journal-title":"Nat Med"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.10.051_bib35","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection","volume":"68","author":"Borrow","year":"1994","journal-title":"J Virol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.10.051_bib36","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome","volume":"68","author":"Koup","year":"1994","journal-title":"J Virol"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2009.10.051_bib37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques","volume":"189","author":"Jin","year":"1999","journal-title":"J Exp Med"},{"issue":"February (5403)","key":"10.1016\/j.vaccine.2009.10.051_bib38","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.10.051_bib39","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm.2013","article-title":"Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts","volume":"15","author":"Sodora","year":"2009","journal-title":"Nat Med"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2009.10.051_bib40","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1128\/JVI.76.14.7187-7202.2002","volume":"76","author":"Horton","year":"2002","journal-title":"J Virol"},{"issue":"January (7225)","key":"10.1016\/j.vaccine.2009.10.051_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature07469","article-title":"Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys","volume":"457","author":"Liu","year":"2009","journal-title":"Nature"},{"issue":"November (18)","key":"10.1016\/j.vaccine.2009.10.051_bib42","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1097\/QAD.0b013e3282f08b32","article-title":"Early restoration of mucosal CD4 memory CCR5 T cells in the gut of SIV-infected rhesus predicts long term non-progression","volume":"21","author":"Ling","year":"2007","journal-title":"AIDS"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2009.10.051_bib43","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.4049\/jimmunol.179.5.3035","article-title":"Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence","volume":"179","author":"Pandrea","year":"2007","journal-title":"J Immunol"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2009.10.051_bib44","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.4049\/jimmunol.179.5.3026","article-title":"Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys","volume":"179","author":"Gordon","year":"2007","journal-title":"J Immunol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.10.051_bib45","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1172\/JCI33034","article-title":"Understanding the benign nature of SIV infection in natural hosts","volume":"117","author":"Silvestri","year":"2007","journal-title":"J Clin Invest"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2009.10.051_bib46","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.vaccine.2008.12.017","article-title":"Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge","volume":"27","author":"Schell","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09015813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09015813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T09:59:06Z","timestamp":1590227946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09015813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0264410X09015813"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.10.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}